Further multivariate Cox regression analysis was performed to select 6-gene prognostic signature (FADD, GABARAPL2, MYC, RAB24, RUBCN, and NPC1) and calculated the risk score of the prostate cancer patients. This evidence concerns the gene MYC and prostate carcinoma.